Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
Unverzagt S, Machemer MT, Solms A, Thiele H, Burkhoff D, Seyfarth M, de Waha A, Ohman EM, Buerke M, Haerting J, Werdan K, Prondzinsky R. Unverzagt S, et al. Among authors: prondzinsky r. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007398. doi: 10.1002/14651858.CD007398.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2015 Mar 27;(3):CD007398. doi: 10.1002/14651858.CD007398.pub3 PMID: 21735410 Updated. Review.
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Prondzinsky R, et al. Crit Care Med. 2010 Jan;38(1):152-60. doi: 10.1097/CCM.0b013e3181b78671. Crit Care Med. 2010. PMID: 19770739 Clinical Trial.
Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M. Prondzinsky R, et al. Shock. 2012 Apr;37(4):378-84. doi: 10.1097/SHK.0b013e31824a67af. Shock. 2012. PMID: 22266974 Clinical Trial.
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R. Unverzagt S, et al. Among authors: prondzinsky r. Cochrane Database Syst Rev. 2014 Jan 2;(1):CD009669. doi: 10.1002/14651858.CD009669.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Jan 29;1:CD009669. doi: 10.1002/14651858.CD009669.pub3 PMID: 24385385 Updated. Review.
90 results